Week in Review, July 8–12

Editor accused of fraud leaves post; the good and the bad of gut microbiota; bacterial gene shuffle; legal restrictions hamper illicit drug research; antibodies and autism

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

FLICKR, JOHN MARTINEZ PAVLIGALast week, The Scientist reported that Dmitry Kuznetsov, a Russian biochemist with a long history of fraud allegations, had taken the role as chief editor of two new journals launched in 2011. The misconduct accusations against Kuznetsov, if true, amount to “one of the worst fraud records in the history of science,” said Dan Larhammar, a professor at Uppsala University in Sweden who has written about problems in Kuznetsov's work. “That should be a major concern to” the publisher that recruited Kuznetsov as editor-in-chief, he said.

This week, Kuznetsov sent reporter Kerry Grens a series of emails between himself and Manisha Basu, an editor at the journals’ publisher, ScienceDomain International, which revealed that Kuznetsov was leaving his posts. Still, the biochemist denies any wrongdoing, even offering explanations for why researchers had been unable to replicate his results or had trouble locating some of the allegedly “missing” papers cited in his publications.

WIKIMEDIA, CDCTwo new studies out this week tell an interesting story about the microbes that inhabit our gastrointestinal tracts: certain microbes in the colon may speed disease progression in HIV patients; and select strains of Clostridium bacteria proved beneficial in mouse models of colitis and allergy. HIV patients on antiretroviral treatment harbored variable gut microbial communities, some quite similar to healthy individuals and others more similar to untreated patients, whose microbiomes harbored a greater proportion of members of the Proteobacteria family and fewer members of Clostridia and Bacteroidia families. Interestingly, the more abnormal a patient’s microbiome, the greater immune cell activity and the higher the levels of inflammatory molecules in their blood. The researchers suspect that viral replication in the mucosa of the intestines can weaken the barrier, allowing the peaceful microbial inhabitants of the gut to leak into the surrounding tissues, causing inflammation and the proliferation of the immune cells that are susceptible to HIV infection.

In the second study, the researchers built on previous findings that germ-free mice treated with a cocktail of a few dozen strains of Clostridia promoted the activity of regulatory T cells (Treg) in the colon, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Jef Akst

    Jef Akst was managing editor of The Scientist, where she started as an intern in 2009 after receiving a master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo